Anebulo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021
Market Capitalization	70	60	121	159
Market Cap Growth	-	-50.38%	-23.75%	-
Enterprise Value	63	49	107	139
PE Ratio	-5.91	-5.13	-17.78	-4.14
PB Ratio	10.81	5.68	8.06	7.44
P/FCF Ratio	-6.47	-6.22	-22.33	-32.68
P/OCF Ratio	-6.47	-6.22	-22.33	-32.68
EV/EBITDA Ratio	-5.30	-4.18	-15.65	-4.60
EV/EBIT Ratio	-5.30	-4.18	-15.65	-4.60
EV/FCF Ratio	-5.78	-5.06	-19.65	-28.58
Quick Ratio	6.56	10.52	28.39	82.71
Current Ratio	6.73	10.92	30.40	89.61
Interest Coverage	-328.54	-	-	-2569.97
Return on Equity (ROE)	-109.40%	-80.70%	-38.40%	-362.10%
Return on Assets (ROA)	-98.40%	-74.70%	-37.80%	-311.70%
Return on Capital (ROIC)	-164.36%	-111.15%	-45.34%	-16.88%
Earnings Yield	-14.96%	-19.48%	-5.62%	-24.16%
FCF Yield	-13.66%	-16.07%	-4.48%	-3.06%
Buyback Yield / Dilution	-0.61%	-7.41%	-71.49%	-
Total Shareholder Return	-0.61%	-7.41%	-71.49%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).